European Union #5817 (v.1)
Base data
- Notified in
-
G/MA/QR/N/EU/4/Add.3 10/06/2020G/MA/QR/N/EU/5/Add.5 08/07/2021G/MA/QR/N/EU/7 07/11/2024G/MA/QR/N/EU/7/Rev.1 03/02/2025
- Version validity
-
04/06/2020 -
present
Current active version v.1
- Reporting member
- European Union
- In force from
- End date
- In force
- General description
-
Estonia: Export prohibition of medicinal products
- National legal basis
-
Decision by the State Agency of Medicines
Basis: § 20(6) of the Medicinal Products Act
https://www.ravimiamet.ee/en/import-and-export-goods-require-special-authorisation-including-medicinal-products - Administrative mechanism
-
Estonian State Agency of Medicines
The measure is temporary - Responsible entities
-
Estonian State Agency of Medicines
- HS version
-
HS 2017
- Referenced WTO document symbol
Meta data
- WTO justifications
-
No specific provision provided
No specific provision provided
Reported as: Protection of human life or health, inter alia - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- P-X
Symbol |
---|
P-X
|
Tariff lines
|
NA
|
1. Diovan 80 mg film-coated tablets N28 (SIA "Novartis Baltics") 2. Diovan 160 mg film-coated tablet...
|
|